Full Text View
Tabular View
No Study Results Posted
Related Studies
Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)
This study has been completed.
Study NCT00001965   Information provided by National Institutes of Health Clinical Center (CC)
First Received: January 18, 2000   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiomyopathy, Hypertrophic
Heart Hypertrophy
Additional conditions recognized in this trial
Cardiomegaly
Cardiomyopathies
Hypertrophy
Hypertrophy, Left Ventricular
More general conditions related to this trial
Aortic Stenosis, Subvalvular
Aortic Valve Stenosis
Cardiovascular Diseases
Heart Diseases
Heart Valve Diseases
Pathological Conditions, Anatomical
Interventions listed in this trial
Cyclosporine A
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services